Research programme: anti-infectives - Arpida/Polyphor

Drug Profile

Research programme: anti-infectives - Arpida/Polyphor

Alternative Names: Anti-infectives research programme - Arpida/Polyphor; Research programme: antibacterials - Arpida/Polyphor; Research programme: antifungals - Arpida/Polyphor

Latest Information Update: 17 Apr 2008

Price : $50

At a glance

  • Originator Arpida; Polyphor
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections; Mycoses

Most Recent Events

  • 17 Apr 2008 Discontinued - Preclinical for Mycoses in European Union (unspecified route)
  • 17 Apr 2008 Discontinued - Preclinical for Bacterial infections in European Union (unspecified route)
  • 13 Nov 2003 Preclinical trials in Mycoses in Europe (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top